VANESSA PEREZ: Open Payments
NPI 1194418350 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 24 payments from 10 companies in 2025. Trend: 2023 $708 · 2024 $786 · 2025 $1,089
Food & beverage: $993Education: $96
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $297 |
| AstraZeneca Pharmaceuticals LP | 3 | $190 |
| Novo Nordisk Inc | 1 | $125 |
| Incyte Corporation | 4 | $115 |
| SOBI, INC | 3 | $104 |
| Syndax Pharmaceuticals, Inc. | 3 | $99 |
| Lilly USA, LLC | 3 | $75 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Radius Health, Inc. | 1 | $25 |
Products named: CALQUENCE, Xospata, Wegovy, JAKAFI, Vonjo, JAYPIRCA, Cresemba, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
